OCULAR THERAPEUTIX, INCOCUL

Market cap

$2.3B

P/E ratio

	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	37	31	33	42	54	54	228	164	102	196	392
Accounts receivable, net	0	0	0	0	0	3	12	21	21	26	32
Inventory	0	0	0	0	0	1	1	1	2	2	3
Prepaid expenses and other current assets	1	2	1	1	2	2	5	5	4	8	13
Total current assets	76	107	70	43	56	60	246	191	130	232	441
Property and equipment, net	2	3	3	10	10	10	8	7	10	12	9
Restricted cash	-	-	-	-	-	-	-	-	-	-	2
Operating lease assets	-	-	-	-	-	7	6	5	8	6	6
Total assets	78	110	75	55	73	79	262	205	149	252	458
Accounts payable	1	2	2	4	3	3	3	5	5	4	4
Accrued Liabilities, Current	3	3	5	4	6	8	14	20	24	29	35
Deferred revenue	-	-	-	-	-	-	-	-	1	0	0
Operating lease liabilities	-	-	-	-	-	1	1	2	2	2	2
Total current liabilities	6	5	8	13	9	12	27	26	31	35	41
Operating Lease, Liability, Noncurrent	-	-	-	-	-	9	8	6	9	7	5
Derivative liabilities	-	-	-	-	-	12	98	20	6	30	13
Deferred revenue, net of current portion	-	-	-	-	-	-	12	13	13	14	14
Notes payable, net	14	15	14	12	25	25	17	25	25	66	69
Other non-current liabilities	-	-	-	-	-	-	-	-	0	0	0
Convertible Notes, net	-	-	-	-	-	24	24	26	29	9	-
Total liabilities	19	21	23	29	37	82	186	117	114	161	143
Common Stock, Value, Issued	0	0	0	0	0	0	0	0	0	0	0
Additional paid-in capital	148	219	226	263	333	380	615	634	652	789	1,206
Accumulated deficit	-89	-129	-174	-237	-297	-384	-539	-546	-617	-698	-891
Total stockholders' equity	59	90	52	26	36	-4	76	88	35	91	315
Total liabilities and stockholders' equity	78	110	75	55	73	79	262	205	149	252	458